Publication | Closed Access

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

Psychoactive DrugPsychiatryPsychotic DisorderMedicinePsychotropic MedicationPsychopharmacologySchizophreniaNeuropharmacologyNew PerspectiveSocial SciencesNeuroscienceBiological PsychiatryTaar1 AgonistsControl BodyPharmacologyPsychopathology